EXELA Trademark

Trademark Overview

On Thursday, June 27, 2013, a trademark application was filed for EXELA with the United States Patent and Trademark Office. The USPTO has given the EXELA trademark a serial number of 85971452. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, February 22, 2024. This trademark is owned by Exela Holdings, Inc.. The EXELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *
exela

General Information

Serial Number85971452
Word MarkEXELA
Filing DateThursday, June 27, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, February 22, 2024
Registration Number4739675
Registration DateTuesday, May 19, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2013

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the statement, line 9 after disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer is inserted.
Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 10, 2013
Primary Code005
First Use Anywhere DateTuesday, January 20, 2015
First Use In Commerce DateTuesday, January 20, 2015

Trademark Owner History

Party NameExela Holdings, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645

Trademark Events

Event DateEvent Description
Thursday, May 29, 2014SOU EXTENSION 1 FILED
Monday, July 1, 2013NEW APPLICATION ENTERED
Wednesday, July 10, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 1, 2013ASSIGNED TO EXAMINER
Monday, October 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 19, 2013PUBLISHED FOR OPPOSITION
Tuesday, November 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 29, 2014SOU TEAS EXTENSION RECEIVED
Monday, June 23, 2014SOU EXTENSION 1 GRANTED
Saturday, March 21, 2015STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 18, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 9, 2015SOU TEAS EXTENSION RECEIVED
Friday, January 9, 2015SOU EXTENSION 2 FILED
Tuesday, January 27, 2015SOU EXTENSION 2 GRANTED
Wednesday, January 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 4, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, February 4, 2015USE AMENDMENT FILED
Saturday, April 11, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 19, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 19, 2020TEAS SECTION 8 & 15 RECEIVED
Friday, April 10, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 20, 2017TEAS SECTION 7 REQUEST RECEIVED
Wednesday, December 20, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 21, 2017AMENDMENT UNDER SECTION 7 - PROCESSED
Thursday, May 21, 2020COUNTERCLAIM OPP. NO. 999999
Tuesday, April 27, 2021NOTICE OF SUIT
Wednesday, May 5, 2021NOTICE OF SUIT
Monday, November 29, 2021NOTICE OF SUIT
Monday, February 19, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 22, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 22, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 22, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, May 19, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

exela pharmaceutical substances treatment preparations immune system psychiatric hormonal related dermatological